CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
 

BIIB's EPS Net Growth by Quarter and Year

Biogen Inc 's EPS Net results by quarter and year




BIIB EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 1.70 3.83 2.50 2.32
III Quarter September -0.47 7.84 2.22 4.46
II Quarter June 4.07 7.24 2.99 9.59
I Quarter March 2.67 2.06 2.69 8.08
FY   7.97 20.97 10.40 24.45



BIIB EPS Net fourth quarter 2023 Y/Y Growth Comment
Biogen Inc reported drop in EPS Net in the fourth quarter 2023 by -55.62% to $ 1.70 , from the same quarter in 2022.
The fall in the fourth quarter 2023 Biogen Inc 's EPS Net compares unfavorably to the Company's average EPS Net jump of 60.74%.

According to the results reported in the fourth quarter 2023, Biogen Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While Biogen Inc ' s EPS Net meltdown of -55.62% ranks overall at the positon no. 258 in the fourth quarter 2023.




BIIB EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -55.62 % 53.2 % 7.76 % -71.32 %
III Quarter September - 253.15 % -50.22 % -46.84 %
II Quarter June -43.78 % 142.14 % -68.82 % 22.17 %
I Quarter March 29.61 % -23.42 % -66.71 % 13.01 %
FY   -61.99 % 101.63 % -57.46 % -22.33 %

Financial Statements
Biogen Inc 's fourth quarter 2023 EPS Net $ 1.70 BIIB's Income Statement
Biogen Inc 's fourth quarter 2022 EPS Net $ 3.83 Quarterly BIIB's Income Statement
New: More BIIB's historic EPS Net Growth >>


BIIB EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -51.15 % 12.61 % -47.98 %
III Quarter September - 8.29 % -25.75 % -53.49 %
II Quarter June 52.43 % 251.46 % 11.15 % 18.69 %
I Quarter March -30.29 % -17.6 % 15.95 % -0.12 %
FY (Year on Year)   -61.99 % 101.63 % -57.46 % -22.33 %




EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #20
Overall #258

EPS Net Y/Y Growth Statistics
High Average Low
1590 % 60.74 % -75 %
(June 30. 2007)   (June 30. 2006)
EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #20
Overall #258
EPS Net Y/Y Growth Statistics
High Average Low
1590 % 60.74 % -75 %
(June 30. 2007)   (June 30. 2006)

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biogen Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's IV. Quarter Q/Q EPS Net Comment
Improvement IV. Quarter 2023where Biogen Inc published EPS Net of $ 1.70 may be beginning of improved results.Biogen Inc announced in the IV. Quarter 2023 EPS Net of $ 1.70 compare to EPS net loss recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Biogen Inc achieved highest sequential EPS Net growth. While Biogen Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's IV. Quarter Q/Q EPS Net Comment
This turnaround IV. Quarter 2023where Biogen Inc published EPS Net of $ 1.70 could be considered as a inception of better business climet.Biogen Inc announced in the IV. Quarter 2023 EPS Net of $ 1.70 compare to EPS net loss recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Biogen Inc achieved highest sequential EPS Net growth. While Biogen Inc 's EPS Net growth quarter on quarter, overall rank is .


Biogen Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ 7.97 $ 10.10 $ 18.41 $ 21.58 $ 20.97
Y / Y EPS Net Growth (TTM) -61.99 % -48.58 % 31.31 % 120.9 % 101.65 %
Year on Year EPS Net Growth Overall Ranking # 61 # 163 # 267 # 115 # 1354
Seqeuential EPS Net Change (TTM) -21.07 % -45.14 % -14.69 % 2.91 % 6.77 %
Seq. EPS Net Growth (TTM) Overall Ranking # 258 # 301 # 385 # 1126 # 787




Cumulative EPS Net growth Comment
Biogen Inc 's cumulative 12 months EPS Net continue to drop, but on the faster rate at -61.99% year on year, at Dec 31 2023 compare to the -48.58% decrease at Sep 30 2023. If the Biogen Inc 's fiscal year would end at Dec 31 2023, annual EPS Net would be $8 .

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 61, from total ranking in previous quarter at 163.

EPS Net TTM Q/Q Growth Statistics
High Average Low
1590 %
60.74 %
-75 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 4
Overall # 61

EPS Net TTM Y/Y Growth Statistics
High Average Low
1590 %
60.74 %
-75 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 20
S&P 500 # 258
Cumulative EPS Net growth Comment
Biogen Inc 's cumulative 12 months EPS Net continue to drop, but on the faster rate at -61.99% year on year, at Dec 31 2023 compare to the -48.58% decrease at Sep 30 2023. If the Biogen Inc 's fiscal year would end at Dec 31 2023, annual EPS Net would be $8 .

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 61, from total ranking in previous quarter at 163.

EPS Net TTM Q/Q Growth Statistics
High Average Low
1590 %
60.74 %
-75 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 4
Overall # 61

EPS Net TTM Y/Y Growth Statistics
High Average Low
1590 %
60.74 %
-75 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 20
S&P 500 # 258




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
BIIB's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for BIIB's Competitors
EPS Net Growth for Biogen Inc 's Suppliers
EPS Net Growth for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons



Companies with similar EPS Net drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2023
Charles River Laboratories International inc -1.31%$ -1.311 
Encompass Health Corporation-3.73%$ -3.731 
Regeneron Pharmaceuticals Inc -4.07%$ -4.066 
Haemonetics Corporation-4.69%$ -4.688 
Edwards Lifesciences Corporation-5.96%$ -5.957 
Resmed Inc -7.19%$ -7.190 
Bristol myers Squibb Company-8.78%$ -8.778 
Avenue Therapeutics Inc -11.55%$ -11.547 
Gilead Sciences Inc -11.97%$ -11.969 
Utah Medical Products Inc-14.08%$ -14.084 
Masimo Corp-18.55%$ -18.550 
Merit Medical Systems Inc-18.93%$ -18.927 
Qiagen N v -19.57%$ -19.565 
Avantor Inc -22.62%$ -22.616 
Fresenius Medical Care Ag-26.09%$ -26.087 
Mettler toledo International Inc -28.51%$ -28.506 
Star Equity Holdings Inc -29.22%$ -29.218 
Harmony Biosciences Holdings inc -38.72%$ -38.717 
Amedisys Inc -39.32%$ -39.315 
Avanos Medical Inc -39.47%$ -39.469 
Pro dex Inc -41.67%$ -41.667 
Embecta Corp -42.62%$ -42.623 
Becton Dickinson And Company-43.53%$ -43.529 
Bio techne Corp-45.16%$ -45.161 
Amgen Inc -52.98%$ -52.977 
Biogen Inc -55.59%$ -55.590 
Taro Pharmaceutical Industries Ltd-56.13%$ -56.129 
Bio rad Laboratories Inc -56.74%$ -56.736 
Integra Lifesciences Holdings Corp-60.46%$ -60.461 
Henry Schein Inc-60.47%$ -60.467 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com